Passage Bio, Inc.
PASG
$0.3905
$0.012.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.82% | 24.07% | 28.66% | 32.97% | 51.33% |
| Total Depreciation and Amortization | -75.06% | -10.90% | -20.77% | -18.51% | -17.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 214.86% | 1,161.50% | -26.87% | -49.96% | -57.15% |
| Change in Net Operating Assets | 45.70% | -29.37% | 691.61% | -85.29% | -150.74% |
| Cash from Operations | 26.85% | 56.73% | 61.14% | 23.36% | 15.67% |
| Capital Expenditure | -- | -7.69% | -400.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 54.63% | 79.85% | -33.25% | -92.55% | 18.87% |
| Cash from Investing | 56.95% | 79.97% | -33.33% | -92.50% | 19.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 2.17% | -- | -4.49% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 2.17% | -- | -4.49% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.16% | 144.49% | 128.77% | -289.58% | 1,325.71% |